(Q44938145)

7 December 2017

title

Simulation of the impact of atropisomer interconversion on plasma exposure of atropisomers of an endothelin receptor antagonist (English)

1 reference

7 December 2017

Zhou YS

1

1 reference

7 December 2017

Tay LK

series ordinal

2

1 reference

7 December 2017

Hughes D

series ordinal

3

1 reference

7 December 2017

Donahue S

series ordinal

4

1 reference

7 December 2017

publication date

1 July 2004

1 reference

The Journal of Clinical Pharmacology

7 December 2017

published in

1 reference

7 December 2017

volume

44

1 reference

7 December 2017

issue

7

1 reference

7 December 2017

page(s)

680-688

1 reference

Enantiomeric drug development: issues, considerations, and regulatory requirements

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270004266622

Chirality in new drug development. Clinical pharmacokinetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004266622

Enantiomers of thalidomide: blood distribution and the influence of serum albumin on chiral inversion and hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004266622

Clinical pharmacology of thalidomide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004266622

Intravenous formulations of the enantiomers of thalidomide: pharmacokinetic and initial pharmacodynamic characterization in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004266622

Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004266622

21 January 2018

Identifiers

DOI

10.1177/0091270004266622

1 reference

7 December 2017

1 reference